Clinical Trial Update: REMIDEP-HTA Program for Hypertension Remission and Medication Deprescription [NA]

View source ↗

Summary

A clinical trial entry describing the REMIDEP-HTA program aimed at hypertension remission and medication deprescription for essential hypertension; the study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Snippet

Sponsor: Evelyn Vanina Re | Conditions: Essential Hypertension | NA | Status: NOT_YET_RECRUITING